Personalized medicine in development by type 2015

This statistic displays the percentage of personalized medicines in development by type as of 2015. In 2015, 42 percent of all drugs in development had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines. Personalized medicines are medicines that, based on a patients biomarkers or biology, may be more a effective treatment option.

本统计数据显示，截至2015年，按类型划分的个性化药物在研发中的占比。2015年，所有研发药物中，有42%具有成为个性化药物的潜力，而在肿瘤学药物中，这一比例高达73%。所谓个性化药物，是指基于患者的生物标志物或生物学特性，可能成为更有效的治疗选择的药物。